Choose languange: English|Japanese
denizli escort sex izle porno bodrum escort

Pharmaceutical Market in Japan in 2012

  • Innomedica
  • Pharmaceutical Market in Japan in 2012
March 5, 2013

Pharmaceutical Market in Japan in 2012

The total market size of the pharmaceutical products in Japan was  103 billion USD in 2012. Blopress by Takeda Pharmaceutical for
blood pressure treatment was sold worth 1.23 billion USD making it the best selling pharma product of the year in Japan.

The indication group with the biggest sales was oncology. The top sales of the oncology products were:

  1. Avastin (Chugai, 850 million USD +16 %),
  2. TS-1 (Taiho Pharmaceutical, 446 million USD, -1.6 %),
  3. Glivec (Novartis, 409 million USD, -6.3 %),
  4. Herceptin (Chugai, 376 million USD, +11.4 %) and
  5. Vectibix (Takeda Pharmaceutical, 215 million USD, 14.3 %).

Leave a Comment

(required)

(required)

(required)


Stay connected with us in your favorite flavor!